Inflammatory lipid mediators in ischemic retinopathy

Pharmacological Reports

Volumn 57, Issue SUPPL., 2005, Pages 169-190

  Hardy, Pierre ^a   Beauchamp, Martin ^a   Sennlaub, Florian ^a   Gobeil, Fernand ^b   Mwaikambo, Bupe ^c   Lachapelle, Pierre ^b   Chemtob, Sylvain ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Isoprostanes; Nuclear receptors; Platelet activating factors ischemia; Prostanoids; Retinopathy; Thromboxane

Indexed keywords

FREE RADICAL; ICOSANOID; LIPID; MEMBRANE PHOSPHOLIPID; OXYGEN; PHOSPHOLIPASE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROSTANOID; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2;

BLINDNESS; CELL DAMAGE; CELL DEATH; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; LIPID PEROXIDATION; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROLIFERATIVE RETINOPATHY; RETINA BLOOD VESSEL; RETINA DISEASE; RETINA INJURY; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; RETROLENTAL FIBROPLASIA; REVIEW; SECOND MESSENGER; VISUAL IMPAIRMENT;

EID: 33645653341     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (262)

1. Abran D, Dumont I, Hardy P, Peri K, Li DY, Molotchnikoff S, Varma DR, Chemtob S: Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development. Circ Res, 1997, 80, 463-472.
2. Abran D, Hardy P, Varma DR, Chemtob S: Mechanisms of the biphasic effects of peroxides on the retinal vasculature of newborn and adult pigs. Exp Eye Res, 1995, 61, 285-292.
3. Abran D, Li DY, Varma DR, Chemtob S: Characterization and ontogeny of PGE2 and PGF2 alpha receptors on the retinal vasculature of the pig. Prostaglandins, 1995, 50, 253-267.
4. Abran D, Varma DR, Chemtob S: Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol, 1995, 268, H628-H632.
5. Abran D, Varma DR, Li DY, Chemtob S: Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane. Can J Physiol Pharmacol, 1994, 72, 168-173.
6. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N et al.: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA, 1995, 92, 10457-10461.
7. Akisu M, Kultursay N, Coker I, Huseyinov A: Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate, 1998, 74, 439-444.
8. Alloatti G, Montrucchio G, Camussi G: Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. J Pharmacol Exp Ther, 1994, 269, 766-771.
9. Alm A, Bill A: Ocular circulation. In: Adler's Physiology of the Eye: Clinical Application. Ed. Moses RA, Hart WM, Mosby, St. Louis, 1992, 198-247.
10. Alm A, Bill A: The oxygen supply to the retina. I. Effects of changes in intraocular and arterial blood pressures, and in arterial P O2 and P CO2 on the oxygen tension in the vitreous body of the cat. Acta Physiol Scand, 1972, 84, 261-274.
11. Alm A, Bill A: The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand, 1972, 84, 306-319.
12. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med, 1995, 1, 1024-1028.
13. Anderson SM, Krinsky NI: Protective action of carotenoid pigments against photodynamic damage to liposomes. Photochem Photobiol, 1973, 18, 403-408.
14. Arita H, Nakano T, Hanasaki K: Thromboxane A2: its generation and role in platelet activation. Prog Lipid Res, 1989, 28, 273-301.
15. Armstrong D, al Awadi F: Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med, 1991, 11, 433-436.
16. Arstila AU, Smith MA, Trump BF: Microsomal lipid peroxidation: morphological characterization. Science, 1972, 175, 530-533.
17. Ashton AW, Yokota R, John G, Zhao S, Suadicani SO, Spray DC, Ware JA: Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2). J Biol Chem, 1999, 274, 35562-35570.
18. Ashton N: Donders lecture, 1967. Some aspects of the comparative pathology of oxygen toxicity in the retina. Br J Ophthalmol, 1968, 52, 505-531.
19. Ashton N: Effect of oxygen on the vessels of the ratling. VIII: studies in developing retial vessels VIII. Br J Ophthalmol Vis Sci, 1994, 35, 3169-3177.
20. Ashton N: Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture. Am J Ophthalmol, 1966, 62, 412-435.
21. Ashton N: Retinal vascularization in health and disease. Am J Ophthalmol, 1957, 44, 7-17.
22. Auge N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R: Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J, 1995, 309 (Pt 3) 1015-1020.
23. Aveldano de Caldironi MI, Giusto NM, Bazan NG: Poly-unsaturated fatty acids of the retina. Prog Lipid Res, 1981, 20, 49-57.
24. Bada HS, Korones SB, Perry EH, Arheart KL, Ray JD, Pourcyrous M, Magill HL et al.: Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. J Pediatr, 1990, 117, 607-614.
25. Baker RR: Enzymes of platelet activating factor synthesis in brain. Neurochem Res, 1995, 20, 1345-1351.
26. Balsinde J, Balboa MA, Insel PA, Dennis EA: Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol, 1999, 39, 175-189.
27. Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B et al.: Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta, 1994, 1209, 130-139.
28. Bazan HE, Hurst JS, Bazan NG: Differences in the acyl composition of the platelet-activating factor (PAF) precursor and other choline phosphoglycerides of the rabbit retinal rod outer segments and neural retina. Curr Eye Res, 1994, 13, 45-50.
29. Bazan NG: Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. Adv Exp Med Biol, 1976, 72, 317-335.
30. Bazan NG: Metabolism of arachidonic acid in the retina and retinal pigment epithelium: biological effects of oxygenated metabolites of arachidonic acid. Prog Clin Biol Res, 1989, 312, 15-37.
31. Bazan NG: The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog Brain Res, 1998, 118, 281-291.
32. Bazan NG, Reddy TS, Bazan HE, Birkle DL: Metabolism of arachidonic and docosahexaenoic acids in the retina. Prog Lipid Res, 1986, 25, 595-606.
33. Beauchamp MH, Marrache AM, Hou X, Gobeil F Jr, Bernier SG, Lachapelle P, Abran D et al.: Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 2002, 43, 3327-3337.
34. Beauchamp MH, Martinez-Bermudez AK, Gobeil F Jr, Marrache AM, Hou X, Speranza G, Abran Det al.: Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy. J Appl Physiol, 2001, 90, 2279-2288.
35. Beausang-Linder M: Sympathetic effects on cerebral and ocular blood flow in rabbits pretreated with indomethacin. Acta Physiol Scand, 1982, 114, 211-215.
36. Berg OG, Gelb MH, Tsai MD, Jain MK: Interfacial enzymology: the secreted phospholipase A(2)-paradigm. Chem Rev, 2001, 101, 2613-2654.
37. Berkowitz BA, Penn JS: Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci, 1998, 39, 840-845.
38. Bhattacharya M, Peri K, Ribeiro-da-Silva A, Almazan G, Shichi H, Hou X, Varma DR, Chemtob S: Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem, 1999, 274, 15719-15724.
39. Bhattacharya M, Peri KG, Almazan G, Ribeiro-da-Silva A, Shichi H, Durocher Y, Abramovitz M et al.: Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci USA, 1998, 95, 15792-15797.
40. Bhattacharya M, Varma DR, Chemtob S: Nuclear prostaglandin receptors. Gene Ther Mol, 1999, Biol 4, 323-338.
41. Bkaily G, Choufani S, Hassan G, El Bizri N, Jacques D, D'Orleans-Juste P: Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J Cardiovasc Pharmacol, 2000, 36, S414-S417.
42. Bkaily G, Pothier P, D'Orleans-Juste P, Simaan M, Jacques D, Jaalouk D, Belzile F et al.: The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem, 1997, 172, 171-194.
43. Bonne C, Muller A, Villain M: Free radicals in retinal ischemia. Gen Pharmacol, 1998, 30, 275-280.
44. Bonventre JV: Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J Lipid Mediat Cell Signal, 1996, 14, 15-23.
45. Booz GW, Conrad KM, Hess AL, Singer HA, Baker KM: Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology, 1992, 130, 3641-3649.
46. Bossi E, Koerner F: Retinopathy of prematurity. Intensive Care Med, 1995, 21, 241-246.
47. Brooks SE, Gu X, Samuel S, Marcus DM, Bartoli M, Huang PL, Caldwell RB: Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci, 2001, 42, 222-228.
48. Brown SM, Jampol LM: New concepts of regulation of retinal vessel tone. Arch Ophthalmol, 1996, 114, 199-204.
49. Bunting S, Moncada S, Vane JR: The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull, 1983, 39, 271-276.
50. Bussolino F, Camussi G: Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem, 1995, 229, 327-337.
51. Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM: Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem, 1998, 273, 4012-4020.
52. Carlotti F, Dower SK, Qwarnstrom EE: Dynamic shuttling of nuclear factor kappa B between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J Biol Chem, 2000, 275, 41028-41034.
53. Castagnet PI, Giusto NM: Properties of phospholipase A2 activity from bovine retinal rod outer segments. Exp Eye Res, 1993, 56, 709-719.
54. Castagnet PI, Roque ME, Pasquare SJ, Giusto NM: Phosphorylation of rod outer segment proteins modulates phosphatidylethanolamine N-methyltransferase and phospholipase A2 activities in photoreceptor membranes. Comp Biochem Physiol B Biochem Mol Biol, 1998, 120, 683-691.
55. Chakraborti S: Phospholipase A(2) isoforms: a perspective, Cell Signal, 2003, 15, 637-665.
56. Chakraborti T, Das S, Mondal M, Roychoudhury S, Chakraborti S: Oxidant, mitochondria and calcium: an overview. Cell Signal, 1999, 11, 77-85.
57. Chanez P, Dent G, Yukawa T, Barnes PJ, Chung KF: Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur Respir J, 1990, 3, 1002-1007.
58. Chan-Ling T, Stone J: Retinopathy of prematurity: origins int he architecture of the retina. Prog Retinal Eye Res, 1992, 12, 155-178.
59. Chan-Ling T, Tout S, Hollander H, Stone J: Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 1992, 33, 2129-2147.
60. Checchin D, Hou X, Hardy P, Abran D, Najarian T, Beauchamp MH, Bernier SG, Gobeil F Jr et al.: PGE(2)-mediated eNOS induction in prolonged hypercapnia. Invest Ophthalmol Vis Sci, 2002, 43, 1558-1566.
61. Chemtob S, Beauchamp M, Hardy P, Hou X, Checchin D, Varma DR, Lachapelle P: Pathogenesis of retinopathy of prematurity. Prog Neonatol, 2001, 21, 161-198.
62. Chemtob S, Beharry K, Rex J, Chatterjee T, Varma DR, Aranda JV: Ibuprofen enhances retinal and choroidal blood flow autoregulation in newborn piglets. Invest Ophthalmol Vis Sci, 1991, 32, 1799-1807.
63. Chemtob S, Hardy P, Abran D, Li DY, Peri & Cuzzani O, Varma DR: Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol, 1995, 78, 2039-2046.
64. Chemtob S, Roy MS, Abran D, Fernandez H, Varma DR: Prevention of postasphyxial increase in lipid peroxides and retinal function deterioration in the newborn pig by inhibition of cyclooxygenase activity and free radical generation. Pediatr Res, 1993, 33, 336-340.
65. Chin MS, Nagineni CN, Hooper LC, Detrick B, Hooks JJ: Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci, 2001, 42, 2338-2346.
66. Christie PE, Henderson WR Jr: Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. Clin Allergy Immunol, 2002, 16, 233-254.
67. Cluzel J, Doly M, Bazan NG, Bonhomme B, Braquet P: Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins. Ophthalmic Res, 1995, 27, 153-157.
68. Crouch MF, Simson L: The G-protein G(i) regulates mitosis but not DNA synthesis in growth factor-activated fibroblasts: a role for the nuclear translocation of G(i). FASEB J, 1997, 11, 189-198.
69. Daemen FJ: Vertebrate rod outer segment membranes. Biochim Biophys Acta, 1973, 300, 255-288.
70. D'Amore PA, Sweet E: Effects of hyperoxia on microvascular cells in vitro. In Vitro Cell Dev Biol, 1987, 23, 123-128.
71. Das A, McLamore A, Song W, McGuire PG: Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthalmol, 1999, 117, 498-503.
72. De La Cruz JP, Moreno A, Ruiz-Ruiz MI, Sanchez DLC: Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. Thromb Res, 2000, 97, 125-131.
73. Delaey C, Boussery K, d Van V: A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest Ophthalmol Vis Sci, 2000, 41, 3555-3560.
74. Delmelle M: Possible implication of photooxidation reactions in retinal photo-damage. Photochem Photobiol, 1979, 29, 713-716.
75. Delton-Vandenbroucke I, Grammas P, Anderson RE: Polyunsaturated fatty acid metabolism in retinal and cerebral microvascular endothelial cells. J Lipid Res, 1997, 38, 147-159.
76. Dennis EA: Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem, 1994, 269, 13057-13060.
77. Dharma, S, Bazan HE, Peyman GA, Atef MS: Production of platelet-activating factor in photocoagulated retinas. Curr Eye Res, 1991, 10, 1031-1035.
78. D'Santos CS, Clarke JH, Divecha N: Phospholipid signalling in the nucleus. Een DAG uit het leven van de inositide signalering in de nucleus. Biochim Biophys Acta, 1998, 1436, 201-232.
79. Dumont I, Hardy P, Peri KG, Hou X, Molotchnikoff S, Varma DR, Chemtob S: Regulation of endothelial nitric oxide synthase by PGD(2) in the developing choroid. Am J Physiol Heart Circ Physiol, 2000, 278, H60-H66.
80. Dumont I, Hou X, Hardy P, Peri KG, Beauchamp M, Najarian T, Molotchnikoff S et al.: Developmental regulation of endothelial nitric oxide synthase in cerebral vessels of newborn pig by prostaglandin E(2). J Pharmacol Exp Ther PG, 1999, 297, 627-633.
81. Dumont I, Peri KG, Hardy P, Hou X, Martinez-Bermudez AK, Molotchnikoff S, Varma DR, Chemtob S: PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period. Am J Ph, 1998, 275, 1812-1821.
82. Eggena P, Zhu JH, Clegg K, Barrett JD: Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension, 1993, 22, 496-501.
83. Ehinger B, Falck B: Concomitant adrenergic and parasympathetic fibres in the rat iris. Acta Physiol Scand, 1966, 67, 201-207.
84. Engerman RL, Kern TS: Retinopathy in animal models of diabetes. Diabetes Metab Rev, 1995, 11, 109-120.
85. Fliesler SJ, Anderson RE: Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res, 1983, 22, 79-131.
86. Flower RW, McLeod DS, Wajer SD, Sendi GS, Egner PG, Dubin NH: Prostaglandins as mediators of vasotonia in the immature retina. Pediatrics, 1984, 73, 440-444.
87. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J, Schiffman J et al.: A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med, 1992, 326, 1050-1054.
88. Frayser R, Rennie ID, Gray GW, Houston CS: Hormonal and electrolyte response to exposure to 17,500 ft. J Appl Physiol, 1975, 38, 636-642.
89. Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA: Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA, 1996, 93, 9764-9769.
90. Friedman E, Chandra SR: Choroidal blood flow. 3. Effects of oxygen and carbon dioxide. Arch Ophthalmol, 1972, 87, 70-71.
91. Fuchsjager-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, Schmetterer L: Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci, 2003, 44, 728-733.
92. Funk CD: Prostaglandins and leukotrienes: advances in eicosanoid biology. Science, 2001, 294, 1871-1875.
93. Gariano RF: Cellular mechanisms in retinal vascular development. Prog Retin Eye Res, 2003, 22, 295-306.
94. Gerasimenko OV, Gerasimenko JV, Tepikin AV, Petersen OH: Calcium transport pathways in the nucleus. Pflugers Arch, 1996, 432, 1-6.
95. Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ: Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics, 1990, 86, 405-412.
96. Gidday JM, Park TS: Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet. Invest Ophthalmol Vis Sci, 1993, 34, 2713-2719.
97. Giusto NM, Pasquare SJ, Salvador GA, Castagnet PI, Roque ME, Ilincheta de Boschero MG: Lipid metabolism in vertebrate retinal rod outer segments. Prog Lipid Res, 2000, 39, 315-391.
98. Gobeil F Jr, Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM et al.: Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem, 2003, 278, 38875-38883.
99. Gobeil F Jr, Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, Abran D, Hou X et al.: Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ Res, 2002, 90, 682-689.
100. Gobeil F Jr, Vazquez-Tello A, Marrache AM, Bhattacharya M, Checchin D, Bkaily G, Lachapelle P et al.: Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors. Can J Physiol Pharmacol, 2003, 81, 196-204.
101. Gole GA, Browning J, Elts SM: The mouse model of oxygen-induced retinopathy: a suitable animal model for angiogenesis research. Doc Ophthalmol, 1990, 74, 163-169.
102. Gole GA: Animal models of retinopathy of Prematurity. In: Retinopathy of Prematurity. Ed. Silverman WA, Flynn JT, Blackwell Scientific Publications, Boston, 1985, 53-95.
103. Goligorsky MS, Morgan MA, Lyubsky S, Gross RW, Adams DT, Spitz DR: Establishment of a hydrogen peroxide resistant variant of renal tubular epithelial cells: role of calcium-independent phospholipase A2 in cell damage. Arch Biochem Biophys, 1993, 301, 119-128.
104. Guyton AC: The relationship of cardiac output and arterial pressure control. Circulation, 1981, 64, 1079-1088.
105. Haefliger IO, Flammer J, Beny JL, Luscher TF: Endothelium-dependent vasoactive modulation in the ophthalmic circulation. Prog Retin Eye Res, 2001, 20, 209-225.
106. Halks-Miller M, Henderson M, Eng LF: Alpha tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain. J Neuropathol Exp Neurol, 1986, 45, 471-484.
107. Hanahan D: Platelet activating factor-past, present, and future. Page 1. In: Platelet Activating Factor Receptor (Signal Mechanisms and Molecular Biology). Ed. Shukla SD, Boca Raton, CRC Press, Florida, 2000.
108. Hanna N, Peri KG, Abran D, Hardy P, Doke A, Lachapelle P, Roy MS et al.: Light induces peroxidation in retina by activating prostaglandin G/H synthase. Free Radic Biol Med, 1997, 23, 885-897.
109. Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, Chermob S: A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res, 1998, 83, 721-729.
110. Hardy P, Abran D, Li DY, Fernandez H, Varma DR, Chemtob S: Free radicals in retinal and choroidal blood flow autoregulation in the piglet: interaction with prostaglandins. Invest Ophthalmol Vis Sci, 1994, 35, 580-591.
111. Hardy P, Bhattacharya M, Abran D, Peri KG, Asselin P, Varma DR, Chemtob S: Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition. Invest Ophthalmol Vis Sci, 1998, 39, 1888-1898.
112. Hardy P, Dumont I, Bhattacharya M, Hou X, Lachapelle P, Varma DR, Chemtob S: Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res, 2000, 47, 489-509.
113. Hardy P, Lamireau D, Hou X, Dumont I, Abran D, Nuyt AM, Varma DR, Chemtob S: Major role for neuronal NO synthase in curtailing choroidal blood flow autoregulation in newborn pig. J Appl Physiol, 2001, 91, 1655-1662.
114. Hardy P, Nuyt AM, Abran D, St Louis J, Varma DR, Chemtob S: Nitric oxide in retinal and choroidal blood flow autoregulation in newborn pigs: interactions with prostaglandins. Pediatr Res, 1996, 39, 487-493.
115. Hardy P, Peri KG, Lahaie I, Varma DR, Chemtob S: Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs. Circ Res, 1996, 79, 504-511.
116. Hayreh SS: Segmental nature of the choroidal vasculature. Br J Ophthalmol, 1975, 59, 631-648.
117. Hemler ME, Cook HW, Lands WE: Prostaglandin biosynthesis can be triggered by lipid peroxides. Arch Biochem Biophys, 1979, 193, 340-345.
118. Henkind P, Hansen RI, Szalay J: Ocular circulation. In: Physiology of the Human Eye and Visual System. Ed. Records RE, Harper & Row, New York, 1979, 98-155.
119. Hill DW: The regional distribution of retinal circulation. Ann R Coll Sing Engl, 1977, 59, 470-475.
120. Hirabayashi T, Murayama T, Shimizu T: Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull, 2004, 27, 1168-1173.
121. Holmes JM, Zhang S, Leske DA, Lanier WL: Carbon dioxide-induced retinopathy in the neonatal rat. Curr Eye Res, 1998, 17, 608-616.
122. Hoste AM, Boels PJ, Andries LJ, Brutsaert DL, De Laey JJ: Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro. Invest Ophthalmol Vis Sci, 1990, 31, 1231-1237.
123. Hou X, Gobeil F Jr, Marrache AM, Quiniou C, Brault S, Checchin D, Bernier SG et al.: Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. Am J Physiol Regul Integr Comp Physiol, 2003, 284, R928-R935.
124. Hou X, Roberts LJ 2nd, Gobeil F Jr, Taber D, Kanai K, Abran D, Brault S et al.: Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic Biol Med, 2004, 36, 163-172.
125. Hubel CA, Davidge ST, McLaughlin MK: Lipid hydroperoxides potentiate mesenteric artery vasoconstrictor responses. Free Radic Biol Med, 1993, 14, 397-407.
126. Ishida S, Yamashiro K, Usui T, Kaji Y, Ogura Y, Hida T, Honda Y et al.: Leukocytes mediate retinal vascular re-modeling during development and vaso-obliteration in disease. Nat Med, 2003, 9, 781-788.
127. Ishii S, Nagase T, Shimizu T: Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat, 2002, 68-69, 599-609.
128. Jacob M, Weech PK, Salesse C: Phospholipases A2 of rod outer segment-free bovine retinae are different from well-known phospholipases A2. Biochim Biophys Acta, 1998, 1391, 169-180.
129. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP: Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol, 2001, 158, 147-152.
130. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U et al.: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J, 2004, 18, 1450-1452.
131. Kalgutkar AS, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ: Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science, 1998, 280, 1268-1270.
132. Kaufman PL: Ocular circulation. In: Adler's Physiology of the Eye: Clinical Application. Ed. Cioffi GA, Granstam E, Alm A, St-Louis, CV Mosby, 2002, 747-784.
133. Kiel JW, Shepherd AP: Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci, 1992, 33, 2399-2410.
134. Kiel JW, van Heuven WA: Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci, 1995, 36, 579-585.
135. Kim CG, Park D, Rhee SG: The role of carboxyl-terminal basic amino acids in Gqalpha-dependent activation, particulate association, and nuclear localization of phospholipase C-beta1. J Biol Chem, 1996, 271, 21187-21192.
136. Kinnula VL, Adler KB, Ackley NJ, Crapo JD: Release of reactive oxygen species by guinea pig tracheal epithelial cells in vitro. Am J Physiol, 1992, 262, L708-L712.
137. Kolko M, Christoffersen NR, Barreiro SG, Bazan NG: Expression and location of mRNAs encoding multiple forms of secretory phospholipase A2 in the rat retina. J Neurosci Res, 2004, 77, 517-524.
138. Kondakova IV, Peiretti F, Nalbone G, Lafont H: Phospholipase A stimulation in tumor cells by subtoxic concentration of tert-butyl hydroperoxide. Biochim Biophys Acta, 1995, 1258, 297-302.
139. Kondo T, Kinouchi H, Kawase M, Yoshimoto T: Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neurosci Lett, 1996, 215, 103-106.
140. Kulkarni P, Cai J, Hurst HE: Lipids and nitric oxide in porcine retinal and choroidal blood vessels. J Ocul Pharmacol Ther, 2002, 18, 265-275.
141. Kuo CF, Cheng S, Burgess JR: Deficiency of vitamin E and selenium enhances calcium-independent phospholipase A2 activity in rat lung and liver. J Nutr, 1995, 125, 1419-1429.
142. Kuriyama H, Waki M, Nakagawa M, Tsuda M: Involvement of oxygen free radicals in experimental retinal ischemia and the selective vulnerability of retinal damage. Ophthalmic Res, 2001, 33, 196-202.
143. Lachapelle P, Dembinska O, Rojas LM, Benoit J, Almazan G, Chemtob S: Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia. Can J Physiol Pharmacol, 1999, 77, 48-55.
144. Lahaie I, Hardy P, Hou X, Hassessian H, Asselin P, Lachapelle P, Almazan G et al.: A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol, 1998, 274, R1406-R1416.
145. Lands WE, Sauter J, GW Stone: Oxygen requirement for prostaglandin biosynthesis. Prostaglandins Med, 1978, 1, 117-120.
146. Larsson PK, Claesson HE, Kennedy BP: Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity. J Biol Chem, 1998, 273, 207-214.
147. Laties AM: Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol, 1967, 77, 405-409.
148. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res, 2002, 62, 625-631.
149. Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M: Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem, 1996, 66, 2160-2167.
150. Lee DK, Lanca AJ, Cheng R, Nguyen T, Ji XD, Gobeil F Jr, Chemtob S et al.: Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem, 2004, 279, 7901-7908.
151. Lemasters JJ: V Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol, 1999, 276, G1-G6.
152. Li Q, Puro DG: Adenosine activates ATP-sensitive K(+) currents in pericytes of rat retinal microvessels: role of A1 and A2a receptors. Brain Res, 2001, 907, 93-99.
153. Lind GJ, Cavanagh HD: Identification and subcellular distribution of muscarinic acetylcholine receptor-related proteins in rabbit corneal and Chinese hamster ovary cells. Invest Ophthalmol Vis Sci, 1995, 36, 1492-1507.
154. Lind GJ, Cavanagh HD: Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest Ophthalmol Vis Sci, 1993, 34, 2943-2952.
155. Liu XH, Eun BL, Barks JD: Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res, 2001, 49, 804-811.
156. Liu XH, Eun BL, Silverstein FS, Barks JD: The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res, 1996, 40, 797-803.
157. Lupo G, Anfuso CD, Ragusa N, Strosznajder RP, Walski M, Alberghina M: t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes. Biochim Biophys Acta, 2001, 1531, 143-155.
158. Lynch JM, Henson PM: The intracellular retention of newly synthesized platelet-activating factor. J Immunol, 1986, 137, 2653-2661.
159. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun SD: Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci, 1995, 36, 925-930.
160. Marrache AM, Gobeil F Jr, Bernier SG, Stankova J, Rola-Pleszczynski M, Choufani S, Bkaily G et al.: Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol, 2002, 169, 6474-6481.
161. Marrache AM, Gobeil F Jr, Chemtob S: Intracrine signaling of phospholipid mediators, PAF and LPA, via cognate nuclear G protein-coupled receptors. Gene Ther Mol Biol, 2004, 8, 115-124.
162. Martin CE, Croft KD, van Bockxmeer FM, Constable IJ: The effect of vitreous humour on prostaglandin production by cultured rabbit chorioretinal fibroblasts. Biochim Biophys Acta, 1987, 931, 303-310.
163. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF: Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA, 1997, 94, 13630-13635.
164. Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K: Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. Brain Res, 1996, 709, 296-302.
165. McLeod DS, Brownstein R, Lutty GA: Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 1996, 37, 300-311.
166. McLeod DS, Crone SN, Lutty GA: Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 1996, 37, 1322-1333.
167. McLeod DS, D'Anna SA, Lutty GA: Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci, 1998, 39, 1918-1932.
168. McLeod DS, Lutty GA, Wajer SD, Flower RW: Visualization of a developing vasculature. Microvasc Res, 1987, 33, 257-269.
169. Michibayashi T: Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. Int Angiol, 2002, 21, 260-267.
170. Michoud E, Lecomte M, Lagarde M, Wiernsperger N: In vivo effect of 8-epi-PGF2alpha on retinal circulation in diabetic and non-diabetic rats. Prostaglandins Leukot Essent Fatty Acids, 1998, 59, 349-355.
171. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP et al.: Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA, 1999, 96, 10836-10841.
172. Moncada S, Higgs A, Furchgott R: International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev, 1997, 49, 137-142.
173. Moncada S, Vane JR: Interrelationships between prostacyclin and thromboxane A2. Ciba Found Symp, 1980, 78, 165-183.
174. Montrucchio G, Alloatti G, Camussi G: Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev, 2000, 80, 1669-1699.
175. Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram JF, Shahinfar S, Skinner SL, Wilkinson-Berka JL: Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension, 2000, 36, 1099-1104.
176. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ: Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA, 1992, 89, 10721-10725.
177. Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE et al.: The isoprostanes: unique prostaglandin-like products of free-radical- initiated lipid peroxidation. Drug Metab Rev, 1999, 31, 117-139.
178. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF et al.: Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem, 1994, 269, 4317-4326.
179. Murakami M, Kudo I: Secretory phospholipase A2. Biol Pharm Bull, 2004, 27, 1158-1164.
180. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T et al.: Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem, 2000, 275, 32783-32792.
181. Nielsen JC, Naash MI, Anderson RE: The regional distribution of vitamins E and C in mature and premature human retinas. Invest Ophthalmol Vis Sci, 1988, 29, 22-26.
182. Nielsen PJ, Nyborg NC: Contractile and relaxing effects of arachidonic acid derivatives on isolated bovine retinal resistance arteries. Exp Eye Res, 1990, 50, 305-311.
183. Niesman MR, Johnson KA, Penn JS: Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res, 1997, 22, 597-605.
184. Nyborg NC, Prieto D, Benedito S, Nielsen PJ: Endothelin-1-induced contraction of bovine retinal small arteries is reversible and abolished by nitrendipine. Invest Ophthalmol Vis Sci, 1991, 32, 27-31.
185. Ohkubo H, Chiba S: Vascular reactivities of simian ophthalmic and ciliary arteries. Curr Eye Res, 1987, 6, 1197-1203.
186. Orrenius S, McCabe MJ Jr, Nicotera P: Ca(2+)-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 64-65 Spec No, 1992, 357-364.
187. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J: Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res, 2004, 23, 91-147.
188. Ostwald P, Goldstein IM, Pachnanda A, Roth S: Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci, 1995, 36, 2396-2403.
189. Parys-Van Ginderdeuren R, Malcolm D, Varma DR, Aranda JV, Chemtob S: Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci, 1992, 33, 3378-3384.
190. Patz A: The role of oxygen in retrolental fibroplasia. Trans Am Ophthalmol Soc, 1968, 66, 940-985.
191. Peeters LL, Sheldon RE, Jones MD Jr, Battaglia FC: Retinal and choroidal blood flow in unstressed fetal and neonatal lambs. Pediatr Res, 1980, 14, 1047-1052.
192. Penn JS: Oxygen-induced retinopathy in the rat: a proposed role for peroxidation reactions in the pathogenesis. In: Free Radical Mechanisms of Tissue Injury. Ed. Treinen Moslen M, Smith CV, Boca Raton, CRC Press, Florida, 1992, 177-188.
193. Penn JS, Thum LA, Naash MI: Oxygen-induced retinopathy in the rat. Vitamins C and E as potential therapies. Invest Ophthalmol Vis Sci, 1992, 33, 1836-1845.
194. Penn JS, Tolman BL, Bullard LE: Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radic Biol Med, 1997, 22, 977-984.
195. Penn JS, Tolman BL, Henry MM: Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci, 1994, 35, 3429-3435.
196. Peri KG, Hardy P, Li DY, Varma DR, Chemtob S: Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem, 1995, 270, 24615-24620.
197. Phelps DL, Rosenbaum AL: The role of tocopherol in oxygen-induced retinopathy: kitten model. Pediatrics, 59, Suppl, 1977, 998-1005.
198. Phillis JW, O'Regan MH: A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res Brain Res Rev, 2004, 44, 13-47.
199. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA, 1995, 92, 905-909.
200. Porta M: Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Diabetologia, 1996, 39, 739-744.
201. Pournaras C, Tsacopoulos M, Chapuis P: Studies on the role of prostaglandins in the regulation of retinal blood flow. Exp Eye Res, 1978, 26, 687-697.
202. Provis JM: Development of the primate retinal vasculature. Prog Retin Eye Res, 2001, 20, 799-821.
203. Radomski MW, Palmer RM, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA, 1990, 87, 5193-5197.
204. Raju TN, Langenberg P, Bhutani V, Quinn GE: Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr, 1997, 131, 844-850.
205. Rego AC, Santos MS, Oliveira CR: Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J Neurochem, 1996, 66, 2506-2516.
206. Reiner A, Zagvazdin Y, Fitzgerald ME: Choroidal blood flow in pigeons compensates for decreases in arterial blood pressure. Exp Eye Res, 2003, 76, 273-282.
207. Reynaud X, Dorey CK: Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci, 1994, 35, 3169-3177.
208. Reynaud X, Hansen RM, Fulton AB: Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci, 1995, 36, 2071-2079.
209. Ricci B: Effects of hyperbaric, normobaric and hypobaric oxygen supplementation on retinal vessels in newborn rats: a preliminary study. Exp Eye Res, 1987, 44, 459-464.
210. Ricci B, Calogero G: Oxygen-induced retinopathy in newborn rats: effects of prolonged normobaric and hyperbaric oxygen supplementation. Pediatrics, 1988, 82, 193-198.
211. Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D et al.: Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997, 121, 105-117.
212. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL: Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci, 1994, 35, 4273-4281.
213. Riva CE, Grunwald JE, Petrig BL: Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci, 1986, 27, 1706-1712.
214. Riva CE, Grunwald JE, Sinclair SH: Laser Doppler Velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci, 1983, 24, 47-51.
215. Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH: Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthatmol Vis Sci, 1986, 27, 722-726.
216. Roth AM: Retinal vascular development in premature infants. Am J Ophthalmol, 1977, 84, 636-640.
217. Rui T, Cepinskas G, Feng Q, Ho YS, Kvietys PR: Cardiac myocytes exposed to anoxia-reoxygenation promote neutrophil transendothelial migration. Am J Physiol Heart Circ Physiol, 2001, 281, H440-H447.
218. Sadda SR, Yu YS, de Juan E Jr, Rencs EV, Green WR, Gottsch JD: Photosensitization-induced retinopathy in the newborn beagle. Invest Ophthalmol Vis Sci, 1994, 35, 1202-1211.
219. Saffitz JE, Nash JA, Green KG, Luke RA, Ransnas LA, Insel PA: Immunoelectron microscopic identification of cytoplasmic and nuclear Gs alpha in S49 lymphoma cells. FASEB J, 1994, 8, 252-258.
220. Sakai H, Suzuki T, Murota M, Oketani K, Uchiumi T, Murakami M, Takeguchi N: E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. Br J Pharmacol, 2002, 136, 383-390.
221. Sapirstein A, Bonventre JV: Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts. Biochim Biophys Acta, 2000, 1488, 139-148.
222. Schievella AR, Regier MK, Smith WL, Lin LL: Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem, 1995, 270, 30749-30754.
223. Schmetterer L, Lexer F, Findl O, Graselli U, Eichler HG, Wolzt M: The effect of inhalation of different mixtures of O2 and CO2 on ocular fundus pulsations. Exp Eye Res 63, 1996, 351-355.
224. Schmetterer L, Wolzt M, Lexer F, Alschinger C, Gouya G, Zanaschka G, Fassolt A et al.: The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men. Exp Eye Res, 1995, 61, 685-690.
225. Sennlaub F, Courtois Y, Goureau O: inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci, 2002, 22, 3987-3993.
226. Sennlaub F, Valamanesh E, Vazquez-Tello A, El-Asrar AM, Checchin D, Brault S, Gobeil F et al.: Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation, 2003, 108, 198-204.
227. Shindou H, Ishii S, Uozumi N, Shimizu T: Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem Biophys Res Commun, 2000, 271, 812-817.
228. Shvedova AA, Alekseeva OM, Kuliev IY, Muranov KO, Kozlov Y, Kagan VE: Damage of photoreceptor membrane lipids and proteins induced by photosensitized generation of singlet oxygen. Curr Eye Res, 1982, 2, 683-689.
229. Simm, G Bertsch, H Frank, U Zimmermann, J Hoppe: Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis. J Cell Sci, 1997, 110, (Pt 7), 819-828.
230. Siu AW, To CH: Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro. Clin Exp Optom, 2002, 85, 378-382.
231. Six DA, Dennis EA: The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta, 2000, 1488, 1-19.
232. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci, 1994, 35, 101-111.
233. Spada CS, Nieves AL, Woodward DF: Vascular activities of Prostaglandins and selective prostanoid receptoragonists in human retinal microvessels. Exp Eye Res, 2002, 75, 155-163.
234. Spencer AG, Woods JW, Arakawa T, Singer II, Smith WL: Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem, 1998, 273, 9886-9893.
235. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science, 1992, 258, 1898-1902.
236. Stevens MK, Yaksh TL: Time course of release in vivo of PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 into the brain extracellular space after 15 min of complete global ischemia in the presence and absence of cyclooxygenase inhibition. J Cereb Blood Flow Metab, 1988, 8, 790-798.
237. Stinson AM, Wiegand RD, Anderson RE: Fatty acid and molecular species compositions of phospholipids and diacylglycerols from rat retinal membranes. Exp Eye Res, 1991, 52, 213-218.
238. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor, VEGF) expression by neuroglia. J Neurosci, 1995, 15, 4738-4747.
239. Stone WL, Farnsworth CC, Dratz EA: A reinvestigation of the fatty acid content of bovine, rat and frog retinal rod outer segments. Exp Eye Res, 1979, 28, 387-397.
240. Swartz JG, Mitchell JE: Phospholipase activity of retina and pigment epithelium. Biochemistry, 1973, 12, 5273-5278.
241. Szabo ME, Haines D, Garay E, Chiavaroli C, Farine JC, Hannaert P, Berta A, Garay RP: Antioxidant properties of calcium dobesilate in ischemic/ reperfused diabetic rat retina. Eur J Pharmacol, 2001, 428, 277-286.
242. Szewczyk A: The intracellular potassium and chloride channels: properties, pharmacology and function (review). Mol Membr Biol, 1998, 15, 49-58.
243. Tachibana H, Gotoh F, Ishikawa Y: Retinal vascular autoregulation in normal subjects. Stroke, 1982, 13, 149-155.
244. Tang SS, Rogg H, Schumacher R, Dzau VJ: Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology, 1992, 131, 374-380.
245. Tolentino MJ, Adamis AP: Angiogenic factors in the development of diabetic iris neovascularization and retinopathy. Int Ophthalmol Clin, 1998, 38, 77-94.
246. Trump BF, Berezesky IK: Calcium-mediated cell injury and cell death. FASEB J, 1995, 9, 219-228.
247. Tsacopoulos M, Pournaras CJ: The role of prostaglandins in the regulation of retinal blood flow. Ophtalmologie, 1990, 4, 20-21.
248. van Kuijk FJ, Buck P: Fatty acid composition of the human macula and peripheral retina. Invest Ophthalmol Vis Sci, 1992, 33, 3493-3496.
249. Ventura C, Maioli M, Pintus G, Posadino AM, Tadolini B: Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei. J Biol Chem, 1998, 273, 13383-13386.
250. Whatley RE, Zimmerman GA, McIntyre TM, Prescott SM: Endothelium from diverse vascular sources synthesizes platelet-activating factor. Arteriosclerosis, 1988, 8, 321-331.
251. Winstead MV, Balsinde J, Dennis EA: Calcium-independent phospholipase A(2): structure and function. Biochim Biophys Acta, 2000, 1488, 28-39.
252. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO: Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res, 2003, 22, 1-29.
253. Woodward DF, Regan JW, Lake S, Ocklind A: The molecular biology and ocular distribution of prostanoid receptors. Surv Ophthalmol, 1997, 41 Suppl 2, S15-S21.
254. Wright DH, Abran D, Bhattacharya M, Hou X, Bernier SG, Bouayad A, Fouron JC et al.: Prostanoid receptors: ontogeny and implications in vascular physiology. Am J Physiol Regul Integr Comp Physiol, 2001, 281, R1343-R1360.
255. Yamada H, Yamada E, Hackett SF, Ozaki H, Okamoto N, Campochiaro PA: Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina. J Cell Physiol, 1999, 179, 149-156.
256. Yamamoto S, Kawamura K, James TN: Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc Res Tech, 1998, 40, 479-487.
257. Ye XD, Laties AM, Stone RA: Peptidergic innervation of the retinal vasculature and optic nerve head. Invest Ophthalmol Vis Sci, 1990, 31, 1731-1737.
258. Yoshida A, Yoshida S, Ishibashi T, Kuwano M, Inomata H: Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. Invest Ophthalmol Vis Sci, 1999, 40, 1624-1629.
259. Yousufzai SY, Abdel-Latif AA: Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists. Biochem J, 1985, 228, 697-706.
260. Yu DY, Cringle SJ, Alder VA, Su EN, Yu PK: Intraretinal oxygen distribution and choroidal regulation in the avascular retina of guinea pigs. Am J Pbysiol, 1996, 270, H965-H973.
261. Zhang W, Ito Y, Berlin E, Roberts R, Berkowitz BA: Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci, 2003, 44, 3119-3123.
262. Zhu Y, Park TS, Gidday JM: Mechanisms of hyperoxia-induced reductions in retinal blood flow in newborn pig. Exp Eye Res, 1998, 67, 357-369.